Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity

Open Access

Peer-reviewed

Research Article

Maria Hoeltzenbein ,

* E-mail: Maria.Hoeltzenbein@charite.de

Affiliation Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité Universitätsmedizin Berlin, Berlin, Germany
⨯
Katja Stieler,

Affiliation Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité Universitätsmedizin Berlin, Berlin, Germany
⨯
Mary Panse,

Affiliation Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité Universitätsmedizin Berlin, Berlin, Germany
⨯
Evelin Wacker,

Affiliation Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité Universitätsmedizin Berlin, Berlin, Germany
⨯
Christof Schaefer

Affiliation Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité Universitätsmedizin Berlin, Berlin, Germany
⨯

Reader Comments (0)

Pregnancy
Is the Subject Area "Pregnancy" applicable to this article?

Thanks for your feedback.
Hypertensive disorders in pregnancy
Is the Subject Area "Hypertensive disorders in pregnancy" applicable to this article?

Thanks for your feedback.
Birth
Is the Subject Area "Birth" applicable to this article?

Thanks for your feedback.
Miscarriage
Is the Subject Area "Miscarriage" applicable to this article?

Thanks for your feedback.
Termination of pregnancy
Is the Subject Area "Termination of pregnancy" applicable to this article?

Thanks for your feedback.
Birth weight
Is the Subject Area "Birth weight" applicable to this article?

Thanks for your feedback.
Case series
Is the Subject Area "Case series" applicable to this article?

Thanks for your feedback.
Gout
Is the Subject Area "Gout" applicable to this article?

Thanks for your feedback.